We respectfully request that the Senate Appropriations Subcommittee of Labor, Health and Human Services, Education and Related Agencies include funding for the newly-enacted Cures Acceleration Network in the Fiscal Year (FY) 2011 Labor-HHS appropriations bill.
BIO’s Chief Advocacy Officer Nick Shipley presents comments to the Committee as it considers reforms to encourage capital formation and investment opportunities for all Americans.
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
We respectfully request that the Senate Appropriations Subcommittee of Labor, Health and Human Services, Education and Related Agencies include funding for the newly-enacted Cures Acceleration Network in the Fiscal Year (FY) 2011 Labor-HHS appropriations bill.